Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
-3.11%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$56.8B
AUM Growth
-$682M
Cap. Flow
+$2.14B
Cap. Flow %
3.76%
Top 10 Hldgs %
48.78%
Holding
206
New
24
Increased
85
Reduced
57
Closed
9

Sector Composition

1 Consumer Discretionary 32.5%
2 Communication Services 21.06%
3 Healthcare 12.98%
4 Financials 9.34%
5 Technology 7.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ETSY icon
176
Etsy
ETSY
$5.17B
$4.22M 0.01%
485,000
-731,185
-60% -$6.36M
POWI icon
177
Power Integrations
POWI
$2.51B
$4.01M 0.01%
161,360
FARO
178
DELISTED
Faro Technologies
FARO
$4M 0.01%
124,080
-15,000
-11% -$483K
MCHP icon
179
Microchip Technology
MCHP
$34.8B
$3.98M 0.01%
165,320
REGN icon
180
Regeneron Pharmaceuticals
REGN
$60.1B
$3.64M 0.01%
10,100
-2,600
-20% -$937K
ADAP
181
Adaptimmune Therapeutics
ADAP
$13.5M
$3.49M 0.01%
+429,700
New +$3.49M
FMI
182
DELISTED
Foundation Medicine, Inc.
FMI
$3.18M 0.01%
174,800
SKM icon
183
SK Telecom
SKM
$8.32B
$3.15M 0.01%
94,919
ARMH
184
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$3.12M 0.01%
71,451
CDXS icon
185
Codexis
CDXS
$218M
$3.06M 0.01%
985,133
+120,000
+14% +$373K
KDNY
186
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.95M 0.01%
+46,000
New +$2.95M
BIOA
187
DELISTED
BioAmber Inc.
BIOA
$2.43M ﹤0.01%
579,540
RIO icon
188
Rio Tinto
RIO
$101B
$2M ﹤0.01%
70,626
SNMX
189
DELISTED
Senomyx, Inc.
SNMX
$1.5M ﹤0.01%
578,000
PCRX icon
190
Pacira BioSciences
PCRX
$1.2B
$1.46M ﹤0.01%
27,500
+1,300
+5% +$68.9K
FOMX
191
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.43M ﹤0.01%
219,400
ACTG icon
192
Acacia Research
ACTG
$322M
$1.39M ﹤0.01%
365,820
VALE.P
193
DELISTED
Vale S A
VALE.P
$1.01M ﹤0.01%
323,000
-33,100
-9% -$103K
EFA icon
194
iShares MSCI EAFE ETF
EFA
$65.9B
$621K ﹤0.01%
+10,868
New +$621K
YOKU
195
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
$394K ﹤0.01%
14,343
-37,835
-73% -$1.04M
ONC
196
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
$54K ﹤0.01%
+1,850
New +$54K
EHC icon
197
Encompass Health
EHC
$12.5B
$15K ﹤0.01%
+9,151
New +$15K
MESO
198
Mesoblast
MESO
$1.73B
-67,800
Closed -$863K
NOAH
199
Noah Holdings
NOAH
$819M
-152,950
Closed -$4.27M
BITA
200
DELISTED
Bitauto Holdings Limited
BITA
-109,990
Closed -$3.11M